Antibody-Drug Conjugates

ADCs a big opportunity for Big Pharma say experts

Big Pharma business opportunities driving ADC boom say experts

By Gareth Macdonald

Big Pharma interest in antibody drug conjugates (ADC) hit another high this week with Roche  ,Novartis and AstraZeneca each announcing investments that boost their ability to develop and manufacture these small-molecule monoclonal antibody (mAb) drug...

Italian drugmaker commits to ADC development

Menarini forms ADC manufacturing deal with OBT

By Gareth Macdonald

Menarini has committed millions of euros to an antibody drug conjugate (ADC) clinical development and manufacturing pact with Oxford BioTerapeutics (OBT).